September 25, 2012; 79 (13 Supplement 1) Basic Science
Update on pharmacology of antiplatelets, anticoagulants, and thrombolytics
Esteban Cheng-Ching, Edgar A. Samaniego, Bharath Reddy Naravetla, Osama O. Zaidat, Muhammad Shazam Hussain
First published September 24, 2012, DOI: https://doi.org/10.1212/WNL.0b013e3182695871
Esteban Cheng-Ching
From the Cleveland Clinic Stroke Program (E.C.-C., M.S.H.), Cleveland Clinic, Cleveland, OH; Stanford Stroke Center (E.A.S.), Stanford University, Palo Alto, CA; Neurovascular Service (B.R.N.), University of California, San Francisco; and Neurointerventional Division (O.O.Z.), Vascular and Interventional Neurology, Medical College of Wisconsin, Milwaukee.
Edgar A. Samaniego
From the Cleveland Clinic Stroke Program (E.C.-C., M.S.H.), Cleveland Clinic, Cleveland, OH; Stanford Stroke Center (E.A.S.), Stanford University, Palo Alto, CA; Neurovascular Service (B.R.N.), University of California, San Francisco; and Neurointerventional Division (O.O.Z.), Vascular and Interventional Neurology, Medical College of Wisconsin, Milwaukee.
Bharath Reddy Naravetla
From the Cleveland Clinic Stroke Program (E.C.-C., M.S.H.), Cleveland Clinic, Cleveland, OH; Stanford Stroke Center (E.A.S.), Stanford University, Palo Alto, CA; Neurovascular Service (B.R.N.), University of California, San Francisco; and Neurointerventional Division (O.O.Z.), Vascular and Interventional Neurology, Medical College of Wisconsin, Milwaukee.
Osama O. Zaidat
From the Cleveland Clinic Stroke Program (E.C.-C., M.S.H.), Cleveland Clinic, Cleveland, OH; Stanford Stroke Center (E.A.S.), Stanford University, Palo Alto, CA; Neurovascular Service (B.R.N.), University of California, San Francisco; and Neurointerventional Division (O.O.Z.), Vascular and Interventional Neurology, Medical College of Wisconsin, Milwaukee.
Muhammad Shazam Hussain
From the Cleveland Clinic Stroke Program (E.C.-C., M.S.H.), Cleveland Clinic, Cleveland, OH; Stanford Stroke Center (E.A.S.), Stanford University, Palo Alto, CA; Neurovascular Service (B.R.N.), University of California, San Francisco; and Neurointerventional Division (O.O.Z.), Vascular and Interventional Neurology, Medical College of Wisconsin, Milwaukee.
Update on pharmacology of antiplatelets, anticoagulants, and thrombolytics
Esteban Cheng-Ching, Edgar A. Samaniego, Bharath Reddy Naravetla, Osama O. Zaidat, Muhammad Shazam Hussain
Neurology Sep 2012, 79 (13 Supplement 1) S68-S76; DOI: 10.1212/WNL.0b013e3182695871
Citation Manager Formats
Make Comment
See Comments
Disputes & Debates: Rapid online correspondence
No comments have been published for this article.
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Related Articles
- No related articles found.